Cite this answer
Testagen: quick citable summary
Testagen is listed by PeptaHub as a sexual health peptide with a research only legal-status classification. The page summarizes mechanism, research context, common routes, safety notes, and references for writers and AI answer engines.
PeptaHub. “Testagen: Mechanism, Research Context, Safety.” peptahub.com, 2026. https://peptahub.com/peptides/testagen. Licensed CC BY 4.0.
License: Creative Commons Attribution 4.0 International. Link back to https://peptahub.com/peptides/testagen.
What is Testagen?
Testagen is a synthetic tetrapeptide (KEDG) sold in Khavinson's bioregulator range and marketed for testicular support. No biological study of it could be located in any species, so its testosterone claims are unverified.
Overview
Testagen is a synthetic tetrapeptide (Lys-Glu-Asp-Gly, KEDG) sold as part of Professor Vladimir Khavinson's bioregulator range and marketed for testicular and male reproductive support. No biological study of Testagen in testicular tissue could be located in PubMed, in any species. Its testosterone-related positioning is a marketing claim, not a demonstrated effect.
Mechanism of action
No mechanism has been established for Testagen. The general Khavinson model holds that short peptides enter the nucleus and interact with double-stranded DNA to influence transcription, and Fedoreyeva and colleagues did show that fluorescently labeled short peptides penetrate the nucleus of HeLa cells and interact with DNA in vitro. Nothing links that to steroidogenesis. The claim that Testagen upregulates the testosterone biosynthetic enzymes CYP11A1, 3-beta-HSD and CYP17A1, and the claim that it acts on the hypothalamic-pituitary-thyroid axis, have no located source and should be regarded as unsupported.
Reported study ranges
No reported study ranges available yet.
Research summary
There is no located biological research on Testagen. PubMed returns two records for the term: the Fedoreyeva in vitro peptide-DNA study covering short peptides generally, and an unrelated 2025 materials-chemistry paper on the peptide's corrosion-inhibiting behavior on copper surfaces. No animal study, no human study, and no measurement of testosterone or Leydig cell function with this peptide could be found. Statements circulating about improved Leydig function or steroidogenic gene expression in aged testicular tissue have no traceable source study.[1]
Evidence grading
Each claimed benefit is graded by the strength of available evidence. Grades reflect study quality, not effect size.
Strong = multiple RCTs · Moderate = limited trials or observational · Preliminary = animal or in vitro only · Insufficient = anecdotal or no published data
Side effects
Side effects vary by individual. This is not an exhaustive list. Report unusual symptoms to a healthcare professional.
Common stacks
Peptides commonly paired with Testagen for synergistic effects.
Legal status
Not FDA-approved. Developed and studied in Russia; commercially sold as a cytogen bioregulator supplement. Available in Western markets as a research chemical. Not approved for therapeutic human use outside Russia.
Sourcing & access
Research compound
Testagen is classified as a research compound. Regulatory status varies by jurisdiction. Always verify current legal status and source from vendors providing third-party certificates of analysis (COA).
Frequently asked questions
Testagen is a synthetic tetrapeptide (KEDG) sold as part of the Khavinson bioregulator range and marketed for testicular and male hormonal support. That positioning is not backed by any located study.
This is unknown. The general Khavinson model proposes that short peptides enter the nucleus and interact with DNA to influence transcription, which has been shown in vitro for short peptides as a class. Specific claims that Testagen upregulates the steroidogenic enzymes CYP11A1, 3-beta-HSD and CYP17A1, or that it acts on the thyroid axis, have no located source.
Unknown. No safety data of any kind has been published for Testagen in humans or animals. Anecdotal reports mention mild injection site irritation. It is not FDA-approved.
None that is published. PubMed returns no study measuring testosterone, Leydig cell function, or gene expression in testicular tissue with this peptide. Claims to the contrary in supplier material do not cite a locatable study.